Log In
Print
BCIQ
Print
Print this Print this
 

pacritinib (ONX 0803, SB1518)

  Manage Alerts
Collapse Summary General Information
Company CTI BioPharma Corp.
DescriptionOrally available dual inhibitor of Janus kinase-2 (JAK-2) and FMS-like tyrosine kinase 3 (FLT3; CD135)
Molecular Target Janus kinase-2 (JAK-2) ; FMS-like tyrosine kinase 3 (FLT3) (CD135)
Mechanism of ActionJanus kinase-2 (JAK-2) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today